|
"lin hans hsienhong"的相關文件
顯示項目 6-15 / 33 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T14:59:14Z |
A pilot study of add-on oral hypoglycemic agents in treatment-naïve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin
|
Hsu, Ching-Sheng;Hsu, Shih-Jer;Lin, Hans Hsienhong;Tseng, Tai-Chung;Wang, Chia-Chi;Chen, Ding-Shinn;Kao, Jia-Horng; DING-SHINN CHEN; Hsu, Ching-Sheng; JIA-HORNG KAO; Hsu, Shih-Jer; Lin, Hans Hsienhong; Tseng, Tai-Chung; Wang, Chia-Chi; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:49:32Z |
Interferon-Based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients
|
Hsu, Ching-Sheng; Huang, Chun-Jen; Kao, Jia-Horng; Lin, Hans Hsienhong; Chao, You-Chen; Fan, Yen-Chun; Tsai, Pei-Shan; Polis, Michael Alan; JIA-HORNG KAO; Hsu, Ching-Sheng; Huang, Chun-Jen; Kao, Jia-Horng; Kao, Jia-Horng; Lin, Hans Hsienhong; Lin, Hans Hsienhong; Chao, You-Chen; Fan, Yen-Chun; Fan, Yen-Chun; Tsai, Pei-Shan; Tsai, Pei-Shan; Polis, Michael Alan |
| 臺大學術典藏 |
2018-09-10T08:44:44Z |
Hepatitis C virus and lipid profiles: More questions than answers?
|
Hsu, Ching-Sheng;Kao, Jia-Horng; HSU, CHING-SHENG;KAO, JIA-HORNG; 許景盛;高嘉宏; JIA-HORNG KAO; Hsu, Ching-Sheng; Liu, Wei-Liang; HSU, CHING-SHENG; Chao, You-Chen; KAO, JIA-HORNG; Lin, Hans Hsienhong; Tseng, Tai-Chung; Wang, Chia-Chi; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信 |
| 國立臺灣大學 |
2016 |
Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues
|
Tseng, Kuo-Chih; Tseng, Chih-Wei; Hsieh, Tsai-Yuan; Peng, Cheng-Yuan; Lin, Chih-Lin; Su, Tung-Hung; Tseng, Tai-Chung; Lin, Hans Hsienhong; Wang, Chia-Chi; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg
|
Wang, Chia-Chi; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Tseng, Tai-Chung; Lin, Hans Hsienhong; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus
|
Chen, Huey-Ling; Lee, Chien-Nan; Chang, Chin-Hao; Ni, Yen-Hsuan; Shyu, Ming-Kwang; Chen, Shih-Ming; Hu, Jen-Jan; Lin, Hans Hsienhong; Zhao, Lu-Lu; Mu, Shu-Chi; Lai, Ming-Wei; Lee, Chyi-Long; Lin, Hsien-Ming; Tsai, Ming-Song; Hsu, Jenn-Jeih; Chen, Ding-Shinn; Chan, K. Arnold; Chang, Mei-Hwei; 陳定信; 倪衍玄; 陳建煒; 張美惠; 李建南; 陳慧玲; 張晉豪 |
| 國立臺灣大學 |
2015 |
Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection
|
Hsu, Ching-Sheng; Liu, Wei-Liang; Chao, You-Chen; Lin, Hans Hsienhong; Tseng, Tai-Chung; Wang, Chia-Chi; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 高嘉宏 |
| 國立臺灣大學 |
2015 |
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
|
Peng, Cheng-Yuan; Hsieh, Tsung-Cheng; Hsieh, Tsai-Yuan; Tseng, Kuo-Chih; Lin, Chih-Lin; Su, Tung-Hung; Tseng, Tai-Chung; Lin, Hans Hsienhong; Wang, Chia-Chi; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients
|
Wang, Chia-Chi; Liu, Chen-Hua; Lin, Chih-Lin; Wang, Pin-Chao; Tseng, Tai-Chung; Lin, Hans Hsienhong; Kao, Jia-Horng; 劉振驊; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma
|
Hsu, Ching-Sheng; Chao, You-Chen; Lin, Hans Hsienhong; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 高嘉宏 |
顯示項目 6-15 / 33 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
